Liangfang Zhang Selected Research

Sepsis (Septicemia)

2/2023	Outer Membrane Vesicle-Coated Nanoparticle Vaccine Protects Against Acinetobacter baumannii Pneumonia and Sepsis.
1/2022	Nanotoxoid vaccination protects against opportunistic bacterial infections arising from immunodeficiency.
1/2022	Biomimetic Neutrophil Nanotoxoids Elicit Potent Immunity against Acinetobacter baumannii in Multiple Models of Infection.
10/2017	Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liangfang Zhang Research Topics

Disease

43	Neoplasms (Cancer) 01/2023 - 10/2007
29	Infections 12/2023 - 04/2010
20	Bacterial Infections (Bacterial Infection) 08/2023 - 03/2011
6	Pneumonia (Pneumonitis) 08/2023 - 01/2022
6	Inflammation (Inflammations) 01/2023 - 08/2012
6	Acne Vulgaris 10/2013 - 10/2009
4	Wounds and Injuries (Trauma) 11/2023 - 05/2013
4	Sepsis (Septicemia) 02/2023 - 10/2017
4	Prostatic Neoplasms (Prostate Cancer) 01/2010 - 10/2007
3	Communicable Diseases (Infectious Diseases) 08/2023 - 01/2019
3	Virus Diseases (Viral Diseases) 09/2022 - 02/2021
3	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2013
3	Cataract (Cataracts) 03/2016 - 07/2015
3	Blindness (Hysterical Blindness) 03/2016 - 06/2012
2	Thrombocytopenia (Thrombopenia) 12/2023 - 01/2021
2	Inborn Genetic Diseases (Disease, Hereditary) 09/2022 - 01/2020
2	Trichomonas Infections 01/2021 - 12/2016
2	HIV Infections (HIV Infection) 01/2019 - 01/2018
2	Endophthalmitis (Ophthalmia) 01/2019 - 11/2017
2	Eye Infections 01/2019 - 11/2017
2	Glioma (Gliomas) 01/2019 - 10/2017
2	Atherosclerosis 01/2018 - 03/2015
2	Hypersensitivity (Allergy) 01/2018 - 09/2014
2	Macular Degeneration (Age-Related Maculopathy) 08/2012 - 06/2012
1	Endotoxemia 08/2023
1	Lung Injury 08/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Hyperglycemia 01/2023
1	Insulin Resistance 01/2023
1	Malaria 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Colitis 01/2023
1	Anthrax 12/2022
1	Bacterial Pneumonia 11/2022
1	Bites and Stings (Sting) 01/2022
1	Circulating Neoplastic Cells 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Cross Infection (Nosocomial Infection) 01/2022

Drug/Important Bio-Agent (IBA)

17	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 10/2009
16	VaccinesIBA 08/2023 - 04/2011
10	NanovaccinesIBA 02/2023 - 01/2019
8	AntigensIBA 08/2023 - 10/2007
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2007
6	CytokinesIBA 08/2023 - 10/2017
6	Virulence Factors (Pathogenicity Factors)IBA 01/2019 - 05/2013
6	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017 - 10/2007
6	Liposomes (Liposome)IBA 07/2015 - 10/2009
5	LipidsIBA 01/2023 - 06/2010
5	GoldIBA 01/2021 - 04/2010
4	AntibodiesIBA 12/2023 - 09/2014
4	HydrogelsIBA 08/2023 - 03/2014
4	Bacterial ToxinsIBA 01/2019 - 03/2011
4	PolymersIBA 08/2016 - 06/2010
4	AcidsIBA 04/2011 - 10/2009
3	DNA (Deoxyribonucleic Acid)IBA 08/2023 - 02/2014
3	Docetaxel (Taxotere)FDA Link 01/2023 - 10/2015
3	Peptides (Polypeptides)IBA 07/2020 - 03/2015
3	EnzymesIBA 01/2020 - 12/2014
3	Retinaldehyde (Retinal)IBA 01/2019 - 06/2012
3	LigandsIBA 01/2019 - 06/2010
3	ToxoidsIBA 01/2018 - 12/2013
3	Anti-Infective Agents (Microbicides)IBA 10/2017 - 01/2011
3	Polylactic Acid-Polyglycolic Acid CopolymerIBA 03/2015 - 02/2008
3	antineoplaston A10 (A 10)IBA 01/2010 - 10/2007
2	diazonaphthalenedisulfonic acid (NDS)IBA 12/2023 - 11/2022
2	NeurotoxinsIBA 11/2023 - 11/2022
2	Antiviral Agents (Antivirals)IBA 01/2022 - 02/2021
2	Cancer VaccinesIBA 01/2022 - 03/2015
2	SilverIBA 04/2020 - 01/2018
2	Auranofin (Ridaura)FDA Link 12/2019 - 12/2016
2	Adenosine Triphosphatases (ATPase)IBA 01/2019 - 01/2018
2	Hemolysin Proteins (Hemolysins)IBA 01/2019 - 01/2018
2	Monoclonal AntibodiesIBA 01/2019 - 01/2019
2	AntitoxinsIBA 01/2019 - 12/2013
2	PerforinIBA 01/2019 - 11/2017
2	Interleukin-12 (IL 12)IBA 01/2017 - 02/2014
2	LanosterolIBA 10/2015 - 07/2015
2	Phospholipids (Phosphatides)FDA LinkGeneric 08/2012 - 03/2011
2	Nucleotide AptamersIBA 01/2010 - 10/2007
2	APTIBA 02/2008 - 10/2007
1	LipopolysaccharidesIBA 08/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	Dextran SulfateIBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2023
1	Messenger RNA (mRNA)IBA 09/2022
1	InterferonsIBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	OvalbuminIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Interferon Type IIBA 01/2022

Therapy/Procedure

30	Therapeutics 01/2023 - 10/2007
10	Drug Therapy (Chemotherapy) 01/2023 - 10/2009
8	Immunotherapy 01/2023 - 11/2015
2	Precision Medicine 01/2018 - 01/2012
2	Quantum Dots (Quantum Dot) 08/2015 - 10/2007
2	Transplantation 07/2014 - 01/2013
1	Phototherapy (Light Therapy) 01/2023
1	Induced Hyperthermia (Thermotherapy) 01/2023
1	Treatment Delay 01/2023